Article

Tequila Could Be the Basis for a New Osteoporosis Treatment

In addition to being the most important ingredient in margaritas, substances derived from tequila can play an important role in bone health.

primary care, family medicine, internal medicine, endocrinology, rheumatology, hospital medicine, OBGYN, women’s health, men’s health, osteoporosis, diet, alcohol, tequila

In addition to being the most important ingredient in margaritas, substances derived from tequila can play an important role in bone health.

Not only did new research find that Agave tequilana (or tequila agave) may help maintain bone health, but it could also be the basis for a new osteoporosis treatment. Mercedes López, PhD, led the project at the Center for Research and Advanced Studies (Cinvestav) in Mexico.

Using animal models, the researchers induced osteoporosis in mice by removing their ovaries. The animals were then given agave fructans (polymers that store carbohydrates in some fruits and vegetables). After eight weeks, femur samples were collected in order to assess the absorption of minerals and osteocalcin (a protein that indicates new bone production).

“It was found that mice that consumed this fructans synthesized nearly 50% more of such protein, in addition that the diameter of their bones was higher compared with the subjects which were not supplied with derivatives of the agave,” López explained in a news release.

  • Related: Switching Osteoporosis Therapy to Denosumab Increases Bone Mineral Density

Therefore, even with the presence of osteoporosis, the agave fructans (along with intestinal microbiota) promoted new bone formation. The team specified that the substances interacted with microbiota in the large intestine to create short-chain fatty acids. The minerals become available in the tract and are transported to cells.

“This way, we have a second chance to take advantage of the nutrients that were no longer available to the body. However, it is very important that people have a healthy intestinal microbiome, because only then it is possible that bacteria ferment fructans to transform them into fatty acids,” López continued.

López plans to conduct clinical trials to further evaluate fructans and hopefully develop the findings into a treatment for bone-weakening osteoporosis. She has already applied for a national patent on the strategy.

Also on MD Magazine >>> Red Wine Can Help the Gut Microbiome Prevent Heart Disease

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
Jennifer B. Green, MD: Implementation of Evidence-Based Therapies for T2D | Image Credit: Duke University
Ralph A. DeFronzo, MD: Noxious Nine and Mifepristone for Hypercortisolism in T2D | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.